<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00159328</url>
  </required_header>
  <id_info>
    <org_study_id>UF008</org_study_id>
    <nct_id>NCT00159328</nct_id>
  </id_info>
  <brief_title>Efficacy Study of Magnetic Resonance (MR) Guided Focused Ultrasound in the Treatment of Large Fibroids</brief_title>
  <official_title>Phase 4 Study of Magnetic Resonance Guided Focused Ultrasound Surgery Following Gonadotrophin Releasing Hormone Agonist Treatment for Symptomatic Uterine Fibroids</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Imperial College London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>InSightec-TxSonics</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Imperial College London</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether ablation of uterine fibroids with MR guided
      focused ultrasound following 3 months pre-treatment with Gonadotrophin releasing analogues
      will allow the effective use of this therapy in women with larger fibroids.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2003</start_date>
  <completion_date>December 2006</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Symptom improvement as judged by validated disease specific questionnaire</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in fibroid and uterine volume.</measure>
  </secondary_outcome>
  <enrollment>50</enrollment>
  <condition>Uterine Fibroids</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Magnetic Resonance Guided Focused Ultrasound</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject has given consent

          -  Willing and able to attend all visits

          -  Minimum age 18 with no desire for future fertility

          -  Uterine fibroid &gt; 300 cc on MRI

          -  Normal cervical smear

          -  Screening symptom score &gt;21

          -  Pre or peri-menopausal

          -  Fibroids being device accessible

        Exclusion Criteria:

          -  Pregnancy

          -  Previous GNRH treatment

          -  HRT use

          -  Hormonal Contraception

          -  Patient on dialysis

          -  Haematocrit &lt;25

          -  ASA score &gt; 2

          -  Severe cerebrovascular disease

          -  Anticoagulated

          -  Active pelvic infection or history of PID

          -  Weight&gt; 250 lbs

          -  Any contra-indication to MR imaging

          -  Intolerance to MRI contrast agent

          -  Unable to remain in prone positions for 3hours

          -  IUCD

          -  Abdominal scarring in beam pathway

          -  Breast feeding

          -  Non-perfused fibroid on contrast enhanced images
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>wady m gedroyc</last_name>
    <role>Principal Investigator</role>
    <affiliation>St Mary's Hospital, Imperial College London.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Interventional Magnetic Resonance, St Mary's Hospital</name>
      <address>
        <city>London</city>
        <zip>W2 1NY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <reference>
    <citation>Hindley J, Gedroyc WM, Regan L, Stewart E, Tempany C, Hynyen K, Mcdannold N, Inbar Y, Itzchak Y, Rabinovici J, Kim HS, Geschwind JF, Hesley G, Gostout B, Ehrenstein T, Hengst S, Sklair-Levy M, Shushan A, Jolesz F. MRI guidance of focused ultrasound therapy of uterine fibroids: early results. AJR Am J Roentgenol. 2004 Dec;183(6):1713-9. Erratum in: AJR Am J Roentgenol. 2005 Jan;184(1):348. Hynnen, Kullvro [corrected to Hynyen, Kullervo]; Macdanold, Nathan [corrected to Mcdannold, Nathan]; Kim, Kevin [corrected to Kim, Hyun S]; Gostout, Brian [corrected to Gostout, Bobbie].</citation>
    <PMID>15547216</PMID>
  </reference>
  <reference>
    <citation>Stewart EA, Gedroyc WM, Tempany CM, Quade BJ, Inbar Y, Ehrenstein T, Shushan A, Hindley JT, Goldin RD, David M, Sklair M, Rabinovici J. Focused ultrasound treatment of uterine fibroid tumors: safety and feasibility of a noninvasive thermoablative technique. Am J Obstet Gynecol. 2003 Jul;189(1):48-54.</citation>
    <PMID>12861137</PMID>
  </reference>
  <reference>
    <citation>Tempany CM, Stewart EA, McDannold N, Quade BJ, Jolesz FA, Hynynen K. MR imaging-guided focused ultrasound surgery of uterine leiomyomas: a feasibility study. Radiology. 2003 Mar;226(3):897-905.</citation>
    <PMID>12616023</PMID>
  </reference>
  <verification_date>August 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 9, 2005</study_first_submitted>
  <study_first_submitted_qc>September 9, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 12, 2005</study_first_posted>
  <last_update_submitted>August 12, 2008</last_update_submitted>
  <last_update_submitted_qc>August 12, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 13, 2008</last_update_posted>
  <keyword>Magnetic Resonance Guided Focused Ultrasound</keyword>
  <keyword>Gonadotrophin Releasing Hormone Agonist</keyword>
  <keyword>Uterine Fibroids</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leiomyoma</mesh_term>
    <mesh_term>Myofibroma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

